News

Edwards Lifesciences Corporation announced one-year results from CLASP IID, the first randomized controlled trial that directly compares two contemporary mitral transcatheter edge-to-edge repair (TEER) therapies, as well as one-year results...

El Camino Health’s Norma Melchor Heart & Vascular Institute (HVI) has earned the HeartCARE Center National Distinction of Excellence based on meeting stringent accreditation criteria, and through their ongoing performance registry reporting.

SANTA CLARA, Calif.- Shockwave Medical, Inc. announced that as part of the Calendar Year 2024 Physician Fee Schedule (PFS) final rule, the U.S. Centers for Medicare & Medicaid Services (CMS) has established a Category I Current Procedural...

In the 2024 OPPS final rule, Barostim was reassigned to New Technology APC 1580, which carries an average payment amount of $45,000.

C-GUARDIANS is a pivotal trial designed to evaluate the safety and efficacy of the CGuard™ Carotid Stent System when used to treat symptomatic and asymptomatic carotid artery stenosis in patients undergoing carotid artery stenting (CAS) and...

IRVINE, Calif. -- Inari Medical, Inc., a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced that it has entered into a definitive agreement to acquire...

SCOTTSDALE, Ariz. – Innovative Health, Inc. announced a three-year agreement to support AllSpire Health GPO member hospitals in maximizing the financial and environmental impact of single-use device reprocessing. Innovative Health’s...

The EKOS system uses a combination of ultrasound energy and a low thrombolytic drug dose to restore blood flow in patients with PE and other occlusions in the peripheral vasculature. 

The Abbott HeartMates program aims to create a community of support for people and caregivers impacted by heart conditions. The program will enable participants to share stories and receive emotional support as well as connect with others...

iFR is an innovative pressure-derived index only offered by Philips that is used to assess coronary blockages during interventional procedures. iFR avoids the use of hyperemic agents.